The role of sodium-hydrogen ion exchange in patients undergoing coronary artery bypass grafting

Area of Science:

• Cardiology
• Cardiovascular Physiology
• Pharmacology

Background:

• Sodium-hydrogen ion exchange (NHE) regulates intracellular pH after ischemia and reperfusion.
• Upregulated NHE increases intracellular calcium via the sodium-calcium exchanger, leading to myocardial stunning and cell death.
• NHE inhibition is a potential therapeutic strategy for protecting ischemic/reperfused myocardium.

Purpose of the Study:

• To evaluate the efficacy of cariporide, an NHE inhibitor, in preventing myocardial necrosis in patients undergoing coronary artery bypass grafting (CABG).
• To further explore the protective effects of NHE inhibition in the context of acute cardiac conditions, building on previous trial findings.

Main Methods:

• The study is designed as a randomized, controlled trial.
• Participants include subjects undergoing CABG who are at risk of myocardial necrosis.
• Cariporide will be administered to assess its impact on cardiac events.

Main Results:

• Preclinical studies consistently support the concept that NHE inhibition protects the myocardium.
• The GUARDIAN trial indicated potential benefits of NHE inhibition in CABG subjects.
• The EXPEDITION trial aims to provide further evidence on the efficacy of cariporide.

Conclusions:

• NHE inhibition shows promise as a cardioprotective strategy.
• Cariporide is being investigated as a therapeutic agent to prevent myocardial damage in high-risk CABG patients.
• The EXPEDITION trial is expected to clarify the role of NHE inhibition in managing acute cardiac conditions.